Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
sector : Professional, scientific, and technical services save search
Global Dairy Testing Market Report 2023: New Introductions/ Innovations to Bode-Well for Market Growth - Forecasts to 2030
Published: 2023-02-03 (Crawled : 15:00) - prnewswire.com
NEOG M | $20.29 -3.84% -3.99% 2M
|
Health Technology
|
| O: -2.09%
H: 0.0%
C: 0.0%
global report for growth market
Ambrx Biopharma Strengthens Clinical Leadership with Appointment of Sandra Aung, Ph.D. as Head of Clinical Development
Published: 2023-02-03 (Crawled : 14:00) - biospace.com/
AMAM A | $1.8 -2.7% 3.33% 320K
|
Professional, Scientific, and T...
|
| O: -1.07%
H: 0.0%
C: 0.0%
NKTR | $3.105 3.5% 3.38% 1.5M
|
Health Technology
|
| O: -4.14%
H: 0.0%
C: 0.0%
biopharma
Monte Rosa Therapeutics to Present at Upcoming Investor Conferences
Published: 2023-02-03 (Crawled : 13:00) - globenewswire.com
GLUE | $8.15 14.31% 12.52% 220K
|
Professional, Scientific, and T...
|
| O: 3.21%
H: 0.0%
C: 0.0%
rosa therapeutics
Compass Therapeutics to Participate in the SVB Securities Global Biopharma Conference
Published: 2023-02-02 (Crawled : 15:20) - biospace.com/
CMPX P | $3.94 -0.76% -0.76% 1.3M
|
Professional, Scientific, and T...
|
| O: 4.76%
H: 1.32%
C: -5.02%
biopharma global conference therapeutics
Gain Therapeutics to Participate in Upcoming Scientific and Medical ConferencesGain to present new preclinical data on its lead programs in GBA1-related diseases
Published: 2023-02-02 (Crawled : 15:00) - biospace.com/
GANX | $3.98 2.84% 2.76% 25K
|
Professional, Scientific, and T...
|
| O: 3.27%
H: 0.98%
C: -5.61%
preclinical medical therapeutics
Ehave Provides Progress Update on its HPPD Study with University of Melbourne
Published: 2023-02-02 (Crawled : 15:00) - globenewswire.com
EHVVF | $0.0054 0
|
Professional, Scientific, and T...
| Email alert
Add to watchlist
update study
Definitive Healthcare greatly expands all-payor medical and prescription claims coverage
Published: 2023-02-02 (Crawled : 15:00) - globenewswire.com
DH | $13.12 -4.58% -4.8% 520K
|
Professional, Scientific, and T...
|
| O: 3.46%
H: 4.23%
C: 2.15%
medical
Definitive Healthcare introduces the Atlas Dataset
Published: 2023-02-02 (Crawled : 15:00) - globenewswire.com
DH | $13.12 -4.58% -4.8% 520K
|
Professional, Scientific, and T...
|
| O: 3.46%
H: 4.23%
C: 2.15%
Unicycive Announces Exclusive License and Development Agreement with Lotus for Renazorb in the Republic of Korea
Published: 2023-02-02 (Crawled : 14:00) - globenewswire.com
UNCY | $0.5305 4.02% 3.86% 620K
|
Professional, Scientific, and T...
|
| O: 0.24%
H: 5.16%
C: -7.27%
for license agreement
Xilio Therapeutics to Present at the Guggenheim Healthcare Talks Oncology Day
Published: 2023-02-02 (Crawled : 13:20) - biospace.com/
XLO | $3.63 -2.68% -2.75% 31K
|
Professional, Scientific, and T...
|
| O: 0.0%
H: 7.84%
C: 0.81%
day therapeutics
Singular Genomics Joins the 10x Genomics Compatible Partner Program
Published: 2023-02-02 (Crawled : 13:20) - globenewswire.com
OMIC | $2.96 3.5% 3.38% 93K
|
Professional, Scientific, and T...
|
| O: -1.88%
H: 11.11%
C: 9.58%
genomics program
Reneo Pharmaceuticals to Participate in SVB Securities Global Biopharma Conference
Published: 2023-02-02 (Crawled : 13:00) - globenewswire.com
RPHM | $2.91 9.81% 8.93% 98K
|
Professional, Scientific, and T...
|
| O: 0.38%
H: 4.88%
C: -0.38%
biopharma pharmaceuticals global conference
Vera Therapeutics Announces Pricing of Public Offering of Class A Common Stock
Published: 2023-02-02 (Crawled : 03:00) - globenewswire.com
VERA | $7.22 0.91% 0.9% 960K
|
Professional, Scientific, and T...
|
| O: -15.12%
H: 5.19%
C: 0.35%
offering therapeutics
CLINUVEL Drug Significantly Reduces Critical UV Skin Damage in Fair-Skinned Individuals
Published: 2023-02-02 (Crawled : 01:00) - globenewswire.com
CLVLY | $17.5485 0
|
Professional, Scientific, and T...
| Email alert
Add to watchlist
CLVLF | $17.25 0
|
Health Technology
| Email alert
Add to watchlist
drug skin
Afamelanotide Significantly Reduces UV Skin Damage in a Healthy Population
Published: 2023-02-01 (Crawled : 00:00) - clinuvel.com
CLVLY | $17.5485 0
|
Professional, Scientific, and T...
| Email alert
Add to watchlist
CLVLF | $17.25 0
|
Health Technology
| Email alert
Add to watchlist
skin
Afamelanotide Significantly Reduces UV Skin Damage in a Healthy Population – Technical Note
Published: 2023-02-01 (Crawled : 00:00) - clinuvel.com
CLVLY | $17.5485 0
|
Professional, Scientific, and T...
| Email alert
Add to watchlist
CLVLF | $17.25 0
|
Health Technology
| Email alert
Add to watchlist
skin
The Worldwide Viral Clearance Industry is Expected to Reach $1.1 Billion by 2027: Increase in the Prevalence of Chronic Diseases Drives Growth
Published: 2023-02-01 (Crawled : 20:00) - prnewswire.com
CRL F | $250.35 -3.68% 0.0% 410K
|
Commercial Services
|
| O: 1.14%
H: 3.78%
C: 3.54%
BIO | $470.88 -2.0% -0.0% 93K
|
Health Technology
|
| O: 2.26%
H: 0.0%
C: 0.0%
A | $154.55 -0.61% 0.0% 970K
|
Health Technology
|
| O: 0.69%
H: 0.0%
C: 0.0%
clearance expected growth
Recursion to Participate in Upcoming Investor Conference - February 1, 2023
Published: 2023-02-01 (Crawled : 15:20) - biospace.com/
RXRX P | $9.67 3.2% 3.1% 1.3M
|
Professional, Scientific, and T...
|
| O: -0.48%
H: 5.2%
C: 3.39%
conference
Miromatrix and Baxter Announce Collaborative Research Agreement Aiming to Advance Care for Patients with Acute Liver Failure
Published: 2023-02-01 (Crawled : 15:00) - biospace.com/
MIRO | $3.35 5.44% 20K
|
Professional, Scientific, and T...
|
| O: -0.57%
H: 5.19%
C: -9.8%
BAX | $46.68 -0.7% -0.17% 4.7M
|
Health Technology
|
| O: 0.44%
H: 1.04%
C: 0.85%
care research liver for agreement
Pardes Biosciences to Present at SVB Securities Global Biopharma Conference
Published: 2023-02-01 (Crawled : 14:00) - biospace.com/
PRDS A | $1.92 -4.48% -4.69% 52K
|
Professional, Scientific, and T...
|
| O: 1.49%
H: 3.66%
C: 1.46%
biopharma global conference
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
Your saved searches
Save your searches and get alerts when important news are released.